The genomic landscape of meningiomas can be broadly classified into two subsets that focus on the involvement of the Neurofibromatosis type 2 (NF-2) gene—tumors associated with mutations of NF-2 and tumors with non-NF-2 mutations (Table 1). This evidence concerns the gene NF2 and meningioma.